Enrolling by invitationPhase 4NCT02051062

BT-011 Pharmacokinetics of Botulism Antitoxin Heptavalent in Pediatric Patients

Studying Botulism

Last synced from ClinicalTrials.gov May 5, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Emergent BioSolutions
Principal Investigator: Clinical Development Representative
Emergent BioSolutions
Intervention: Blood sample collection(biological)
Enrollment: 10 enrolled
Eligibility: 11 years · All sexes
Timeline: 2014 – 2028

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02051062 on ClinicalTrials.gov

← Back to all trials